NCT00747604View on ClinicalTrials.gov

IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex

TerminatedOBSERVATIONAL

Enrollment

1,378

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Primary Insulin-like Growth Factor-1 Deficiency

Interventions

BIOLOGICAL

mecasermin [rDNA origin] injection

As prescribed by the physician.

Trial Locations (1)

07920

Ipsen Central Contact, Basking Ridge

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Ipsen

INDUSTRY